DidanosineDrug Administration ScheduleUnited States Food and Drug AdministrationInfusions, IntravenousAdministration, OralDose-Response Relationship, DrugAntineoplastic AgentsAntineoplastic Agents, PhytogenicNeoplasmsAntineoplastic Combined Chemotherapy ProtocolsFluorouracilCamptothecinStavudineTreatment OutcomeAnti-HIV AgentsZidovudineReinforcement ScheduleDeoxycytidinePaclitaxelDrug ApprovalReverse Transcriptase InhibitorsHIV InfectionsDevice ApprovalDrug Therapy, CombinationBenzoxazinesZalcitabineOrganophosphonatesLamivudineHIV-1Equipment SafetyDrug InteractionsCD4 Lymphocyte CountOxazinesAdenineDrug LabelingUnited StatesNevirapineHalf-LifeNelfinavirElephantiasis, FilarialTime FactorsImmunization ScheduleLegislation, DrugDelavirdineHIV Reverse TranscriptaseColumbidaeDideoxynucleosidesAcidosis, LacticInjections, IntravenousFilaricidesAIDS-Related ComplexAntiretroviral Therapy, Highly ActiveAcquired Immunodeficiency SyndromeArea Under CurveHydroxyureaDrug Administration RoutesProduct Surveillance, PostmarketingViral LoadDiethylcarbamazineIndinavirDrug Resistance, ViralHIV Core Protein p24Double-Blind MethodConditioning, OperantReinforcement (Psychology)Chemistry, PharmaceuticalFee SchedulesCross-Over StudiesNucleic Acid Synthesis InhibitorsRNA, ViralRats, Sprague-DawleySaquinavirConsumer Product SafetyAlbendazoleAntiviral AgentsGenes, polInvestigational New Drug ApplicationFood LabelingClinical Trials as TopicAntiparasitic AgentsIvermectinDrug and Narcotic ControlHIV Protease InhibitorsCapsulesTreatment FailureProduct LabelingBiological AvailabilityLegislation, FoodAdministration, IntranasalRats, WistarChromatography, High Pressure LiquidDrug IndustrySelf AdministrationDrug Resistance, Multiple, ViralDisease Models, AnimalDrug EvaluationWuchereria bancroftiHIV-Associated Lipodystrophy SyndromeEquipment and SuppliesBehavior, Animal